X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Aventis Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs MYLAN (US) - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   MYLAN
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
MYLAN
Dec-18
SANOFI INDIA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs6,8403,323-   
Low Rs4,6301,829-   
Sales per share (Unadj.) Rs1,203.11,529.0-  
Earnings per share (Unadj.) Rs165.341.5-  
Cash flow per share (Unadj.) Rs209.9327.8-  
Dividends per share (Unadj.) Rs84.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs963.61,654.1-  
Shares outstanding (eoy) m23.03514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.81.7 282.9%   
Avg P/E ratio x34.762.0 55.9%  
P/CF ratio (eoy) x27.37.9 347.8%  
Price / Book Value ratio x6.01.6 382.2%  
Dividend payout %50.80-   
Avg Mkt Cap Rs m132,0781,325,346 10.0%   
No. of employees `0003.335.0 9.4%   
Total wages/salary Rs m4,0680-   
Avg. sales/employee Rs Th8,393.822,476.8 37.3%   
Avg. wages/employee Rs Th1,232.40-   
Avg. net profit/employee Rs Th1,153.0610.3 188.9%   
INCOME DATA
Net Sales Rs m27,708786,689 3.5%  
Other income Rs m8970-   
Total revenues Rs m28,605786,689 3.6%   
Gross profit Rs m6,235203,566 3.1%  
Depreciation Rs m1,027147,299 0.7%   
Interest Rs m737,837 0.0%   
Profit before tax Rs m6,09818,430 33.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,292-2,932 -78.2%   
Profit after tax Rs m3,80621,362 17.8%  
Gross profit margin %22.525.9 87.0%  
Effective tax rate %37.6-15.9 -236.3%   
Net profit margin %13.72.7 505.9%  
BALANCE SHEET DATA
Current assets Rs m15,922439,286 3.6%   
Current liabilities Rs m6,235320,288 1.9%   
Net working cap to sales %35.015.1 231.1%  
Current ratio x2.61.4 186.2%  
Inventory Days Days6484 76.2%  
Debtors Days Days2193 22.4%  
Net fixed assets Rs m7,539152,605 4.9%   
Share capital Rs m230419 54.9%   
"Free" reserves Rs m21,9620-   
Net worth Rs m22,192851,054 2.6%   
Long term debt Rs m0918,560 0.0%   
Total assets Rs m29,8392,282,857 1.3%  
Interest coverage x872.11.5 58,647.8%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.90.3 269.5%   
Return on assets %12.82.6 492.8%  
Return on equity %17.22.5 683.3%  
Return on capital %27.53.2 865.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4420-   
CASH FLOW
From Operations Rs m3,739163,474 2.3%  
From Investments Rs m-731-84,498 0.9%  
From Financial Activity Rs m-1,972-76,156 2.6%  
Net Cashflow Rs m1,0361,354 76.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 69.81 Rs / USD

Compare SANOFI INDIA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SANOFI INDIA With: CIPLA  AJANTA PHARMA  SUVEN LIFESCIENCES  ALEMBIC PHARMA  FDC LTD.  



Today's Market

Sensex Opens on a Strong Note Tracking Global Cues; Metal & Realty Stocks Lead(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1.7% while the Hang Seng is up 2.4%.

Related Views On News

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jun 19, 2019 10:39 AM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - FDC LTD. COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS